For years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
Our general medicine thought leaders provide innovative development strategies and principled trial design and conduct. They work hand in hand in with market access and regulatory experts, operational teams, and feasibility leaders to ensure that your trials are conducted to exacting standards. General Medicine M.D.s are keenly focused not only on today’s landscape but what the future portends, providing both strategic insight and operational nimbleness across all phases of development.
Our General Medicine group has global expertise in cardiovascular medicine, respiratory medicine, endocrinology and metabolic diseases, nephrology, and women’s health and genitourinary medicine.
Because the needs of patients are at the core of all that we do, each program, from highly prevalent conditions to ultra-rare diseases, and from mega trials with thousands of patients, to trials with very few patients, receives our focus. But we do not just execute. We seek and scrutinize the latest advances in study design and technologies to catapult your program to success.
Our experts in general medicine
Jing Liu, M.D., Ph.D. （劉 静 - ﾘｭｳ ｼﾞﾝ）
Corporate Vice President, Global TA Section Head, Nephrology, Urology
We have far-reaching experience in cardiovascular trials across the entire spectrum of drugs and medical devices, including heart failure, hypertension, pulmonary hypertension, atherosclerosis and myocardial infarction, atrial fibrillation, and thrombosis, to name a few. Our board-certified cardiologists, top-notch biostatisticians, and regulatory, product development, and market access specialists are always ready to optimize study designs and develop strategy.
Two additional strengths are our adjudication services and site and ECG/imaging core laboratory networks. Our adjudication services help ensure the highest quality data, and because we are already engaged in cardiovascular projects across our site network, we’re able to accelerate timelines with our experience and agreed upon contract templates, as well as monitor sites closely to ensure high performance.
Our projects cover the spectrum from small studies of rare metabolic diseases to Type 2 diabetes mega-trials enrolling thousands. We fulfill the unique needs of each study with strong site networks around the world and recruitment solutions, including both adult and pediatric studies. Sensor solutions for diabetes studies are another area of our expertise, including 21 CFR part 11–compliant continuous glucose monitoring (CGM). Our sensor solutions and endocrinology experts have collaborated on solutions to facilitate CGM and glucose-related data capture for diabetes clinical trials. Through partnerships with our vendors, we can offer an integrated central platform for real-time visualization and monitoring of CGM, blood glucose and e-diary information.
Our team includes board-certified adult and pediatric endocrinologists, certified clinical densitometrists, glucose-clamp expertise, and top-quality regulatory, market access, and biostatistics experts.
As we enter a new era with breakthroughs for chronic kidney and urinary system diseases, we are here to help you overcome obstacles — like patient recruitment, payer engagement, and others. Our delivery of major studies in this area demonstrates expertise, including chronic kidney failure, diabetic and polycystic kidney diseases, nephritis, nephropathy, urinary incontinence, overactive bladder, and benign prostatic hyperplasia.
From the millions of individuals affected by asthma and COPD to the few affected by rare diseases, bringing innovation and more affordable treatments to patients is our passion. At Parexel, we have conducted studies in common repsiratory processes involving many thousands of patients at more than 3,000 sites globally, including one of the largest observational asthma trials ever conducted. Likewise, our expertise spans to smaller studies in interstitial lung disease, cystic fibrosis, chronic cough, and orphan diseases.
Through partnerships with the leading pharma companies and biotech innovators, we collaborate across the full ecosystem of respiratory disease research. As a single point of contact, we integrate meaningful data to assess treatment efficacy in an interventional trial and relevant insights in the real world of respiratory disease.
While the ecosystem for women’s health drug development and marketed products has become increasingly complex, we have the experience and success to drive your trials forward. Our expertise spans across a person’s lifetime, encompassing preadolescent care, menstrual and pelvic health, contraception, fertility management, pregnancy, menopausal care, and mental health. We continue to be at the cutting edge of women’s health, supporting all three women’s health products approved by the US FDA in 2020. As the field of women’s health moves beyond patients, health care providers, pharma, payors, and regulators, we are ready to partner with you to accelerate product development.
At Parexel, we have vast expertise in innovative trial design and digital medicine. This includes virtual, decentralized, and adaptive trials, precision and translational medicine, and sensor solutions, which can make your trials not only more accessible, but more impactful.
Benefit from our unparalleled access to trends across indications.
Capitalize on our biotech experience in global, complex trials.
Improve participation with our broad expertise in patient recruitment, including access to pediatrics.
Stay abreast of all updates and development paradigm changes with clear, transparent, and timely communication.
Make trial enrollment more representative with our broad expertise in patient recruitment, as well as our commitment to diversity, equity and inclusion.
Stay abreast of all updates and issues throughout development with clear, transparent communication.
Design and execute trials with patient insights gained from our relationships with patient and caregiver advocacy groups.
Approach or achieve forecasted recruitment rates and timelines built on our site centricity.
Want to hear from our experts on the latest topics in general medicine? Visit our Insights Center to read, watch, and listen.